HART, NANCY B.

Associate Professor
Dept of Clinical Pharmacy

Office: 193 POLK AVENUE
SUITE 2D
NASHVILLE TN 37210
Tel: (615) 532-0223
nhart9@uthsc.edu

Education

  • Pharm.D., University of Florida College of Pharmacy; Gainesville, FL, Pharmacy

My Current CV

Clinical Care Specialty/Interest

 Ambulatory Care; Community Pharmacy; Cultural Competence; Health Disparities

Research Interest/Specialty

 ambulatory care; health disparities; community practice

Publications

  1. Borja-Hart, N, Hohmeier, KC. Availability of drug information on community pharmacy websites in Tennessee. Int J Pharm Pract, 2017.
  2. Battie, CA, Borja-Hart, N, Ancheta, IB, Flores, R, Rao, G, Palaniappan, L. Comparison of body mass index, waist circumference, and waist to height ratio in the prediction of hypertension and diabetes mellitus: Filipino-American women cardiovascular study. Prev Med Rep, 4, 608-613, 2016.
  3. Hohmeier, KC, Borja-Hart, N, Cooper, M, Kirby, J, Fisher, C. Training and retaining community pharmacy leaders: Career pathways after completing a PGY1 community pharmacy residency affiliated with a large supermarket chain. J Am Pharm Assoc (2003), 2016.
  4. Wheeler, JS, Borja-Hart, N, Hagemann, TM. Key Questions to Ask When Establishing a Clinical Practice: What I Wish I Knew When I Started. Hosp Pharm, 51 (9), 699-702, 2016.
  5. Borja-Hart, NL, Leachman, BG. Drug information resources used by chain community pharmacists in Tennessee. Journal of Pharmacy Technology, 5 (32), 185-190, 2016.
  6. Hohmeier, KC, Borja-Hart, N. Are patient's simply unaware? A cross-sectional study of website promotion of community pharmacy adherence-related services in Tennessee. Res Social Adm Pharm, 2015.
  7. Ancheta, IB, Carlson, JM, Battie, CA, Borja-Hart, N, Cobb, S, Ancheta, CV. One size does not fit all: cardiovascular health disparities as a function of ethnicity in Asian-American women. Appl Nurs Res, 28 (2), 99-105, 2015.
  8. Ancheta, IB, Battie, CA, Tuason, MT, Borja-Hart, N, Ancheta, CV. The prevalence of cardiovascular risk factors and diabetes increases with a body mass index of > or = 23 kg/m2 in Filipino American women. Ethn Dis, 24 (1), 48-54, 2014.
  9. Epstein, BJ, Shah, NK, Borja-Hart, NL. Management of hypertension with fixed-dose triple-combination treatments. Ther Adv Cardiovasc Dis, 7 (5), 246-59, 2013.
  10. Gortney, JS, Seed, S, Borja-Hart, N, Young, V, Woodard, LJ, Nobles-Knight, D, Scott, DM, Nash, JD. The prevalence and characteristics of dual PharmD/MPH programs offered at US colleges and schools of pharmacy. Am J Pharm Educ, 77 (6), 116, 2013.
  11. Ancheta, IB, Battie, CA, Richard, D, Ancheta, CV, Borja-Hart, N, Volgman, AS, Conley, Y. The Association between KIF6 Single Nucleotide Polymorphism rs20455 and Serum Lipids in Filipino-American Women. Nurs Res Pract, 2014, 328954, 2013.
  12. Evans, JG, Sutton, DR, Dajani, LH, Magee, JS, Silva, RA, Roura, MF, Wadud, K, Purcell, JA, Travaglini, S, Segel, SA, Sultan, S, Roffman, MS, Ayad, SS, Borja-Hart, NL, Smith, SM. A novel endocrinology-based wellness program to reduce medication expenditures and improve glycemic outcomes. Diabetes Metab Syndr, 7 (2), 87-90, 2013.
  13. Sheikh-Ali, M, Raheja, P, Borja-Hart, N. Medical management and strategies to prevent coronary artery disease in patients with type 2 diabetes mellitus. Postgrad Med, 125 (1), 17-33, 2013.
  14. Caballero, J, Benavides, S, Steinberg, JG, Clauson, KA, Gauthier, T, Borja-Hart, NL, Marino, J. Development of a residency interviewing preparatory seminar. Am J Health Syst Pharm, 69 (5), 400-4, 2012.
  15. Benavides, S, Borja-Hart, NL, Maniscalco-Feichtl, M. Implementation and faculty assessment of an oral examination in a therapeutics course in a distance synchronous education pharmacy programme. Int J Pharm Pract, 19 (6), 438-43, 2011.
  16. Borja-Hart, NL, Maniscalco-Feichtl, M. Development of a comprehensive community pharmacy patient intake form compliant with OBRA'90 requirements. J Pharm Pract, 24 (5), 480-4, 2011.
  17. Borja-Hart, N, Douglas, SM, Marino, J, Garcia, A, Anderson-Worts, P. Preparation for a medical mission to Jamaica--pharmacy's perspective. West Indian Med J, 60 (2), 199-202, 2011.
  18. Stallings, A, Borja-Hart, N, Fass, J. New Practitioners Forum: Strategies for reinventing journal club. Am J Health Syst Pharm, 68 (1), 14-6, 2011.
  19. Borja-Hart, NL, Whalen, KL. Saxagliptin: a new dipeptidyl peptidase 4 inhibitor for type 2 diabetes. Ann Pharmacother, 44 (6), 1046-53, 2010.
  20. Borja-Hart, N, Garcia, A, Anderson-Worts, P. Education plays a major role in a medical mission. J Am Pharm Assoc (2003), 50 (3), 336-7, 2010.
  21. Borja-Hart, NL, Marino, J. Role of omega-3 Fatty acids for prevention or treatment of perinatal depression. Pharmacotherapy, 30 (2), 210-6, 2010.
  22. Chrisphonte, Y, Borja-Hart, NL. Rabies vaccination update. J Am Pharm Assoc (2003), 50 (1), 104-6, 2010.
  23. Singh-Franco, D, Ghin, HL, Robles, GI, Borja-Hart, N, Perez, A. Levocetirizine for the treatment of allergic rhinitis and chronic idiopathic urticaria in adults and children. Clin Ther, 31 (8), 1664-87, 2009.
  24. Borja-Hart, NL, Benavides, S, Christensen, C. Human papillomavirus vaccine safety in pediatric patients: an evaluation of the Vaccine Adverse Event Reporting System. Ann Pharmacother, 43 (2), 356-9, 2009.
  25. Ramirez, MA, Borja, NL. Epalrestat: an aldose reductase inhibitor for the treatment of diabetic neuropathy. Pharmacotherapy, 28 (5), 646-55, 2008.
  26. Borja, NL, Daniel, KL. Ramelteon for the treatment of insomnia. Clin Ther, 28 (10), 1540-55, 2006.